Sterling Capital Management’s Mesa Laboratories MLAB Stock Holding History

Sterling Capital Management’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.89K	Sell	19 -15	-44%	-$1.51K	﹤0.01%	3003
2026 Q1	$3.01K	Sell	34 -2	-6%	-$172	﹤0.01%	2893
2025 Q4	$2.83K	Buy	36 +23	+177%	+$1.75K	﹤0.01%	3019
2025 Q3	$871	Hold	13	–	–	﹤0.01%	3102
2025 Q2	$1.23K	Sell	13 -48	-79%	-$5.27K	﹤0.01%	3029
2025 Q1	$7.24K	Sell	61 -51	-46%	-$6.95K	﹤0.01%	1984
2024 Q4	$14.8K	Buy	112 +99	+762%	+$12.2K	﹤0.01%	1984
2024 Q3	$1.69K	Buy	+13	New	+$1.53K	﹤0.01%	2261

Other funds holding MLAB

LPP

Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Sterling Capital Management's MLAB Position: Q2 2026 in Review

Sterling Capital Management reduced its Mesa Laboratories (MLAB) stake by 44% in Q2 2026, selling an estimated $1.51K and leaving 19 shares worth $1.89K. The position accounts for ﹤0.01% of the portfolio, ranked #3003.

Sterling Capital Management first reported a position in MLAB in Q3 2024 and has held it in 8 quarters since. The position peaked at $14.8K in Q4 2024. 160 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

Sterling Capital Management held 19 shares of Mesa Laboratories worth $1.89K as of Q2 2026.
Sterling Capital Management sold 15 Mesa Laboratories shares in Q2 2026, an estimated $1.51K.
Mesa Laboratories made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #3003 holding.
Sterling Capital Management first reported a position in Mesa Laboratories in Q3 2024 and has held it in 8 quarters since.
Sterling Capital Management's Mesa Laboratories position peaked at $14.8K in Q4 2024.
160 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.